Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena McCormack

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
BMC Medical Ethics|June 15, 2010
How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, TanzaniaAndrew Vallely, Shelley Lees, Charles Shagi, et al.
The International Journal on Drug Policy|November 19, 2019
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participantsCharlotte O'Halloran, Brian Rice, Ellen White, et al.
Trials|February 5, 2013
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west UgandaAndrew Abaasa, Angela Crook, Mitzy Gafos, et al.
Sexually Transmitted Infections|January 10, 2013
Audit of HIV testing frequency and behavioural interventions for men who have sex with men: policy and practice in sexual health clinics in EnglandMonica Desai, Sarika Desai, Ann Kathleen Sullivan, et al.
AIDS and Behavior|February 19, 2022
Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in EnglandDora Arnold-Forster, Robert Horne, Will Nutland, et al.
Trials|March 30, 2023
Electronic health records to capture primary outcome measures: two case studies in HIV prevention researchDavid Dunn, Leanne McCabe, Ellen White, et al.
Human Reproduction (Oxford, England)|May 20, 2014
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trialAngela M Crook, Deborah Ford, Mitzy Gafos, et al.
Plos One|September 21, 2011
The long-term impact of the MEMA kwa Vijana adolescent sexual and reproductive health intervention: effect of dose and time since intervention exposureAoife M Doyle, Helen A Weiss, Kaballa Maganja, et al.
AIDS Research and Human Retroviruses|March 19, 2009
Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et alSheena McCormack, Doug Taylor, Barbra Richardson, et al.
BMJ Open|December 13, 2019
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxisAda Miltz, Fiona Lampe, Sheena McCormack, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
BMC Medical Ethics|June 15, 2010
How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, TanzaniaAndrew Vallely, Shelley Lees, Charles Shagi, et al.
The International Journal on Drug Policy|November 19, 2019
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participantsCharlotte O'Halloran, Brian Rice, Ellen White, et al.
Trials|February 5, 2013
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west UgandaAndrew Abaasa, Angela Crook, Mitzy Gafos, et al.
Sexually Transmitted Infections|January 10, 2013
Audit of HIV testing frequency and behavioural interventions for men who have sex with men: policy and practice in sexual health clinics in EnglandMonica Desai, Sarika Desai, Ann Kathleen Sullivan, et al.
AIDS and Behavior|February 19, 2022
Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in EnglandDora Arnold-Forster, Robert Horne, Will Nutland, et al.
Trials|March 30, 2023
Electronic health records to capture primary outcome measures: two case studies in HIV prevention researchDavid Dunn, Leanne McCabe, Ellen White, et al.
Human Reproduction (Oxford, England)|May 20, 2014
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trialAngela M Crook, Deborah Ford, Mitzy Gafos, et al.
Plos One|September 21, 2011
The long-term impact of the MEMA kwa Vijana adolescent sexual and reproductive health intervention: effect of dose and time since intervention exposureAoife M Doyle, Helen A Weiss, Kaballa Maganja, et al.
AIDS Research and Human Retroviruses|March 19, 2009
Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et alSheena McCormack, Doug Taylor, Barbra Richardson, et al.
BMJ Open|December 13, 2019
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxisAda Miltz, Fiona Lampe, Sheena McCormack, et al.
Pageof 12